John Ligon is an Oncology physician. OpenAlex indexes 118 publications with 1,036 citations (h-index 16); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1800 Orleans St Rm 11379
Baltimore, MD 21287
Telephone
410-955-8751Registry record last updated 31 Jul 2019.
Clinical trials
- RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
Sponsor: University of Florida
- The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey
Sponsor: Blood Cancer United
- Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- National Marrow Donor ProgramProgram year202511 payments
- National Marrow Donor ProgramProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- <i>BRCA2</i> and <i>NF2</i> -Mutated High-Grade Renal Cell Carcinoma: A Case Report and Literature Review
International Journal of Surgical Pathology
2026 - Fertility Outcomes Following CAR T-cell Therapy: Results from a Patient-Facing Survey
Biology of Blood and Marrow Transplantation
2026 - Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading
Nature Biomedical Engineering
2025 - Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor response
Journal of Clinical Investigation
2025 - Systemic mRNA vaccines elicit rapid immune activation in canine brain tumors
Journal for ImmunoTherapy of Cancer
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”